Evidence map›Paper›PMID 26907680›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2016

24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.

Jennifer L Moran, Kazuma Nakagawa, Susan M Asai, Matthew A Koenig

Open access · greenAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 5 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 5 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jennifer L MoranThe Queen's Medical Center, Neuroscience Institute, Honolulu, Hawaii.
Kazuma NakagawaThe Queen's Medical Center, Neuroscience Institute, Honolulu, Hawaii; Department of Medicine, The University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii.
Susan M AsaiThe Queen's Medical Center, Neuroscience Institute, Honolulu, Hawaii.
Matthew A KoenigThe Queen's Medical Center, Neuroscience Institute, Honolulu, Hawaii; Department of Medicine, The University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii. Electronic address: mkoenig@queens.org.
Queen's Medical Center · USUniversity of Hawaiʻi at Mānoa · US

Funding

UNDERSTANDING AND REDUCING ETHNIC DISPARITIES IN PREVENTABLE HOSPITALIZATIONSP20MD000173 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI MAU, MARJORIE K. LEIMOMI MALA · 2002 to 2017
$21.0M
NIMHD NIH HHS P20 MD000173NIMHD NIH HHS P20MD000173
6 · The paper itself

Abstract

backgroundStroke centers with limited on-site neurovascular physician coverage may experience delays in acute stroke treatment. We sought to assess the impact of providing 24/7 neurocritical care acute care nurse practitioner (ACNP) "stroke code" first responder coverage on treatment delays in acute stroke patients who received tissue plasminogen activator (tPA).

methodsConsecutive acute ischemic stroke patients treated with intravenous tPA at a primary stroke center on Oahu between 2009 and 2014were retrospectively studied. 24/7 ACNP stroke code coverage (intervention) was introduced on July 1, 2011. The tPA utilization, door-to-needle (DTN) time, imaging-to-needle (ITN) time, and independent ambulation at hospital discharge were compared between the preintervention period (24 months) and the postintervention period (33 months).

resultsWe studied 166 stroke code patients who were treated with intravenous tPA, 44 of whom were treated during the preintervention period and 122 of whom were treated during the postintervention period. After the intervention, the median DTN time was reduced from 53 minutes (interquartile range [IQR] 45-73) to 45 minutes (IQR 35-58) (P = .001), and the median ITN time was reduced from 36 minutes (IQR 28-64) to 21 minutes (IQR 16-31) (P < .0001). Compliance with the 60-minute target DTN improved from 61.4% (27 of 44 patients) in the preintervention period to 81.2% (99 of 122 patients) in the postintervention period (P = .004). The tPA treatment rates were similar between the preintervention and postintervention periods (P = .60).

conclusionsAddition of 24/7 on-site neurocritical care ACNP first responder coverage for acute stroke code significantly reduced the DTN time among acute stroke patients treated with tPA.

Indexed as

After-Hours CareCritical Care NursingNurse PractitionersPersonnel Staffing and SchedulingTime-to-TreatmentAgedAged, 80 and overFemaleFibrinolytic AgentsHawaiiHumansInfusions, IntravenousLength of StayMaleMiddle AgedPatient DischargeFibrinolytic AgentsTissue Plasminogen Activatornurse practitioneroutcomesstaffing modelsStrokethrombolysis

Identifiers

PMID26907680
PMCPMC5014379
OpenAlexW2283944351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.